Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,228 | 292 | 78.9% |
| Travel and Lodging | $1,633 | 5 | 20.7% |
| Education | $28.65 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $4,092 | 166 | $0 (2023) |
| Nevro Corp. | $749.15 | 22 | $0 (2024) |
| Medtronic, Inc. | $458.72 | 17 | $0 (2024) |
| Vertiflex, Inc. | $421.48 | 6 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $290.03 | 6 | $0 (2024) |
| Amgen Inc. | $250.72 | 13 | $0 (2024) |
| SI-BONE, INC. | $249.48 | 6 | $0 (2023) |
| Abbott Laboratories | $213.59 | 9 | $0 (2021) |
| ABBVIE INC. | $139.63 | 4 | $0 (2024) |
| Medtronic USA, Inc. | $138.09 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,131 | 26 | Nevro Corp. ($547.06) |
| 2023 | $709.61 | 37 | Nevro Corp. ($186.07) |
| 2022 | $381.62 | 22 | Medtronic, Inc. ($192.74) |
| 2021 | $461.96 | 27 | BOSTON SCIENTIFIC CORPORATION ($168.99) |
| 2020 | $413.13 | 34 | Boston Scientific Corporation ($354.01) |
| 2019 | $1,556 | 67 | Boston Scientific Corporation ($689.57) |
| 2018 | $2,551 | 44 | BOSTON SCIENTIFIC CORPORATION ($2,292) |
| 2017 | $684.61 | 41 | BOSTON SCIENTIFIC CORPORATION ($311.80) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | Cash or cash equivalent | $130.20 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/28/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $45.89 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/20/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $19.56 | General |
| 08/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $149.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/09/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $37.97 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 07/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/07/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 05/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Bone Health | ||||||
| 04/16/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Pain Management | ||||||
| 04/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/16/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Pain Management | ||||||
| 03/16/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Pain Management | ||||||
| 03/15/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $127.53 | General |
| Category: Pain Management | ||||||
| 03/15/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | Cash or cash equivalent | $64.13 | General |
| Category: Pain Management | ||||||
| 02/29/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/24/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $80.00 | General |
| Category: Pain management | ||||||
| 02/20/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,330 | 2,064 | $473,455 | $145,108 |
| 2022 | 21 | 1,389 | 1,924 | $552,053 | $151,270 |
| 2021 | 22 | 1,259 | 1,704 | $451,820 | $126,536 |
| 2020 | 17 | 1,177 | 1,584 | $419,065 | $104,051 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 539 | $149,005 | $48,390 | 32.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 137 | 173 | $114,490 | $33,300 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 149 | 149 | $63,695 | $17,622 | 27.7% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 48 | 57 | $38,380 | $11,126 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 151 | $28,342 | $9,827 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 42 | $15,303 | $5,453 | 35.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 17 | 18 | $8,446 | $2,916 | 34.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 48 | 56 | $10,660 | $2,914 | 27.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 52 | 70 | $9,984 | $2,602 | 26.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 15 | 20 | $9,276 | $2,596 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $9,638 | $2,189 | 22.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 129 | 175 | $3,923 | $1,556 | 39.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 16 | $3,832 | $1,518 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 38 | $4,287 | $1,455 | 33.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 108 | 175 | $2,133 | $999.50 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 39 | $312.00 | $305.76 | 98.0% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 11 | 11 | $928.00 | $218.73 | 23.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 130 | $650.00 | $105.14 | 16.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 171 | $171.00 | $16.75 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 670 | $213,645 | $61,023 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 157 | 157 | $75,831 | $19,021 | 25.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 148 | 189 | $56,322 | $13,807 | 24.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 61 | 62 | $45,322 | $12,765 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 159 | $34,662 | $10,525 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 62 | $26,536 | $7,988 | 30.1% |
About Dr. Ralph Menard, MD
Dr. Ralph Menard, MD is a Interventional Pain Medicine healthcare provider based in Fredericksburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407876014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Menard, MD has received a total of $7,889 in payments from pharmaceutical and medical device companies, with $1,131 received in 2024. These payments were reported across 298 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,228).
As a Medicare-enrolled provider, Menard has provided services to 5,155 Medicare beneficiaries, totaling 7,276 services with total Medicare billing of $526,965. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Location Fredericksburg, TX
- Active Since 07/20/2006
- Last Updated 06/28/2017
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1407876014
Products in Payments
- SPECTRA WAVEWRITER (Device) $2,450
- Senza (Device) $733.13
- Superion ISS (Device) $421.48
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $413.49
- GENERAL - PAIN MANAGEMENT (Device) $384.20
- Iovera (Device) $290.03
- GENERAL PAIN MANAGEMENT (Device) $249.94
- WaveWriter Alpha Prime 16 (Device) $220.64
- GENERAL PAIN MANAGEMENT (Device) $174.80
- EVENITY (Biological) $173.34
- IFUSE IMPLANT (Device) $155.20
- INFINION (Device) $148.26
- KYPHON Balloon Kyphoplasty (Device) $147.45
- Proclaim Family of SCS IPGs (Device) $137.70
- WAVEWRITER ALPHA (Device) $119.61
- LINEAR (Device) $114.20
- QULIPTA (Drug) $99.99
- Erleada (Drug) $87.33
- FORTEO (Drug) $84.08
- SPRINT PNS System (Device) $80.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.